Reprogramming Pretrained Target-Specific Diffusion Models for Dual-Target Drug Design (2410.20688v2)
Abstract: Dual-target therapeutic strategies have become a compelling approach and attracted significant attention due to various benefits, such as their potential in overcoming drug resistance in cancer therapy. Considering the tremendous success that deep generative models have achieved in structure-based drug design in recent years, we formulate dual-target drug design as a generative task and curate a novel dataset of potential target pairs based on synergistic drug combinations. We propose to design dual-target drugs with diffusion models that are trained on single-target protein-ligand complex pairs. Specifically, we align two pockets in 3D space with protein-ligand binding priors and build two complex graphs with shared ligand nodes for SE(3)-equivariant composed message passing, based on which we derive a composed drift in both 3D and categorical probability space in the generative process. Our algorithm can well transfer the knowledge gained in single-target pretraining to dual-target scenarios in a zero-shot manner. We also repurpose linker design methods as strong baselines for this task. Extensive experiments demonstrate the effectiveness of our method compared with various baselines.
- Amy C Anderson. 2003. The process of structure-based drug design. Chemistry & biology, 10(9):787–797.
- Announcing the worldwide protein data bank. Nature structural & molecular biology, 10(12):980–980.
- Quantifying the chemical beauty of drugs. Nature chemistry, 4(2):90–98.
- Maria Laura Bolognesi and Andrea Cavalli. 2016. Multitarget drug discovery and polypharmacology.
- Systematic synergy modeling: understanding drug synergy from a systems biology perspective. BMC Systems Biology.
- Prafulla Dhariwal and Alexander Nichol. 2021. Diffusion models beat gans on image synthesis. Advances in neural information processing systems, 34:8780–8794.
- Compositional visual generation with energy based models. Advances in Neural Information Processing Systems, 33:6637–6647.
- Improved contrastive divergence training of energy based models. arXiv preprint arXiv:2012.01316.
- Yilun Du and Igor Mordatch. 2019. Implicit generation and modeling with energy based models. Advances in Neural Information Processing Systems, 32.
- AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings. Journal of chemical information and modeling, 61(8):3891–3898.
- Peter Ertl and Ansgar Schuffenhauer. 2009. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. Journal of cheminformatics, 1(1):1–11.
- LinkerNet: Fragment Poses and Linker Co-Design with 3D Equivariant Diffusion. In Thirty-seventh Conference on Neural Information Processing Systems.
- Energy-inspired molecular conformation optimization. In international conference on learning representations.
- 3D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction. In International Conference on Learning Representations.
- DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design. In Proceedings of the 40th International Conference on Machine Learning, volume 202 of Proceedings of Machine Learning Research, pages 11827–11846. PMLR.
- Denoising diffusion probabilistic models. Advances in neural information processing systems, 33:6840–6851.
- 3DLinker: an E (3) equivariant variational autoencoder for molecular linker design. arXiv preprint arXiv:2205.07309.
- Protein-ligand interaction prior for binding-aware 3d molecule diffusion models. In The Twelfth International Conference on Learning Representations.
- Bliss Chester I. 1939. The toxicity of poisons applied jointly 1. Annals of applied biology, 26(3):585–615.
- Equivariant 3d-conditional diffusion models for molecular linker design. arXiv preprint arXiv:2210.05274.
- Deep generative models for 3D linker design. Journal of chemical information and modeling, 60(4):1983–1995.
- Deep generative design with 3D pharmacophoric constraints. Chemical science, 12(43):14577–14589.
- A landscape of pharmacogenomic interactions in cancer. Cell, 166(3):740–754.
- Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873):583–589.
- Drugbank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Research, 52(D1):D1265–D1275.
- Radoslav Krivák and David Hoksza. 2018. P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. Journal of cheminformatics, 10:1–12.
- The human kinome targeted by FDA approved multi-target drugs and combination products: A comparative study from the drug-target interaction network perspective. PloS one, 11(11):e0165737.
- Diffbp: Generative diffusion of 3d molecules for target protein binding. arXiv preprint arXiv:2211.11214.
- Network analysis of drug–target interactions: a study on FDA-approved new molecular entities between 2000 to 2015. Scientific reports, 7(1):12230.
- DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic acids research, 48(D1):D871–D881.
- Generating 3d molecules for target protein binding. arXiv preprint arXiv:2204.09410.
- Compositional visual generation with composable diffusion models. In European Conference on Computer Vision, pages 423–439. Springer.
- Forging the basis for developing protein–ligand interaction scoring functions. Accounts of chemical research, 50(2):302–309.
- Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. New England Journal of Medicine, 371(20):1877–1888.
- A 3D generative model for structure-based drug design. Advances in Neural Information Processing Systems, 34:6229–6239.
- Combination therapy in combating cancer. Oncotarget, 8(23):38022.
- Pocket2mol: Efficient molecular sampling based on 3d protein pockets. In International Conference on Machine Learning, pages 17644–17655. PMLR.
- Geometric deep learning for structure-based ligand design. ACS Central Science, 9(12):2257–2267.
- Generating 3D molecules conditional on receptor binding sites with deep generative models. Chemical science, 13(9):2701–2713.
- A perspective on multi-target drug discovery and design for complex diseases. Clinical and translational medicine, 7:1–14.
- Improved overall survival in melanoma with combined dabrafenib and trametinib. New England Journal of Medicine, 372(1):30–39.
- Loewe S. 1953. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung, 3(6):285–90.
- E (n) equivariant graph neural networks. In International conference on machine learning, pages 9323–9332. PMLR.
- Structure-based Drug Design with Equivariant Diffusion Models. arXiv preprint arXiv:2210.13695.
- Deep unsupervised learning using nonequilibrium thermodynamics. In International conference on machine learning, pages 2256–2265. PMLR.
- Yang Song and Diederik P Kingma. 2021. How to train your energy-based models. arXiv preprint arXiv:2101.03288.
- Score-Based Generative Modeling through Stochastic Differential Equations. In International Conference on Learning Representations.
- Ronald J Tallarida. 2001. Drug synergism: its detection and applications. Journal of Pharmacology and Experimental Therapeutics, 298(3):865–872.
- AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic acids research, 50(D1):D439–D444.
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model. BMC Systems Biology.
- Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1878(3):188866.
- Deep generative molecular design reshapes drug discovery. Cell Reports Medicine, 3(12).
- Learning Subpocket Prototypes for Generalizable Structure-based Drug Design. arXiv preprint arXiv:2305.13997.
- Molecule generation for target protein binding with structural motifs. In The Eleventh International Conference on Learning Representations.
- DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization. In The Twelfth International Conference on Learning Representations.
- TTD: Therapeutic Target Database describing target druggability information. Nucleic acids research, 52(D1):D1465–D1477.
Sponsored by Paperpile, the PDF & BibTeX manager trusted by top AI labs.
Get 30 days freePaper Prompts
Sign up for free to create and run prompts on this paper using GPT-5.
Top Community Prompts
Collections
Sign up for free to add this paper to one or more collections.